Reliance Pharma Fund - Direct (Bonus)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 18 Aug 2017 125.81 -1.78
(-1.40%)

NAV High-Low (in Rs)

ONE Mth 1469.80
1469.80
52-WEEk 1235.15
1615.51

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 0.48 - - - 6.05
Sensex -0.6 -2.4 8.68 11.33 18.58
Nifty -0.41 -1.62 9.5 12.55 23.61

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 31 Jul 2017
Category Share (%)
CBLO 7.00
Derivatives 0.13
Equity 94.20
› More
   As On 31 Jul 2017
Sector Name Amount
Finance & Investments 2.87
Healthcare 11.23
NA 7.13
Pharmaceuticals - Indian - Bulk Drugs 15.83
Pharmaceuticals - Indian - Bulk Drugs & Formln 47.22
Pharmaceuticals - Multinational 17.05
› More
   As On 31 Jul 2017
Company Name
Aurobindo Pharma 9.78
Divi's Lab. 9.16
Cipla 9.15
Abbott India 9.09
Sun Pharma.Inds. 9.04
Dr Reddy's Labs 8.45
Sanofi India 7.96
Lupin 6.67
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Capital Asset Management Company,

1st Floor Grand Lingam Residency
No.104 Arni Main Road
Sankarapalayam Vellore - 632001

Phone: | Fax:

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com